Opportunity Information: Apply for RFA DA 23 032

The NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional) funding opportunity (RFA-DA-23-032; NEPS Concept #1875) is a National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) grant program designed to directly confront racial and ethnic inequities in substance use and addiction outcomes. It sits under NIDA's broader Racial Equity Initiative, described as a multi-year, multi-pronged effort to address inequities both in the real-world burden of substance use and related harms and within NIDA's overall research portfolio. The main intent is to support research projects that can produce meaningful, practical improvements for communities that experience disproportionate impacts from substance misuse, substance use disorders, and associated health consequences, explicitly including HIV.

This FOA invites applications using the NIH R01 mechanism, which is typically used for substantial, multi-year research projects. The scope is intentionally broad in terms of research stage and approach: proposed studies may identify problems and underlying drivers, develop new strategies or interventions, implement approaches in real-world settings, or rigorously test strategies aimed at improving prevention, treatment, recovery, harm reduction, or related outcomes. The unifying theme is that the work should have strong potential to prevent, reduce, or eliminate disparities affecting racial and ethnic minority populations. The "clinical trial optional" designation means applicants can propose either clinical trial research or non-clinical trial research, depending on what best fits the research question and methods.

A defining requirement of this opportunity is the emphasis on community-engaged research. NIDA is signaling that faster, more useful progress on equity-focused substance use research happens when communities help shape what gets studied and how it gets studied, so the research questions, design, and outcomes reflect immediate needs and practical realities. As a result, applications must be submitted by collaborative, community-partnered investigative teams, and the projects must address issues that are prioritized by the relevant communities rather than solely investigator-driven priorities. In practice, this implies that reviewers will be looking for a clear, credible partnership structure and a strong plan for shared decision-making, relevance, and accountability to community-identified concerns.

The FOA also lowers a common barrier to entry by stating that no preliminary data are required. Instead of expecting extensive pilot results, NIDA is asking applicants to make a compelling case through strong logic and a well-supported rationale that the proposed project has real potential to produce desired outcomes. That puts extra weight on the clarity of the problem statement, the link between the proposed strategy and expected impact, and the feasibility of the approach within the community context.

Eligibility is geared toward U.S.-based institutions, with a notable emphasis on Minority Serving Institutions (MSIs). Eligible applicants include public and state-controlled institutions of higher education and private institutions of higher education. The FOA explicitly calls out several MSI categories as eligible, including Alaska Native and Native Hawaiian Serving Institutions, Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). At the same time, non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are not eligible either. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, meaning a U.S. applicant can include certain international elements when justified and structured according to NIH rules.

From an administrative standpoint, the opportunity is categorized as a discretionary grant under the education and health activity area, with CFDA number 93.279. The opportunity was created on 2022-08-09, and the original closing date listed is 2024-11-14. The notice does not provide an award ceiling amount or an expected number of awards in the provided text, so applicants would need to consult the full FOA and NIH budgeting policies to understand allowable costs, project periods, and any institute-specific funding considerations.

Overall, this FOA is aiming to fund rigorous, high-impact research that is built with communities rather than simply conducted in communities, using the R01 structure to support substantial projects that can change outcomes. The core success factors suggested by the description are: a clear focus on racial and ethnic disparities in substance use, addiction, and related consequences like HIV; a credible, community-prioritized research agenda; and a logically strong, feasible plan for developing, implementing, or testing strategies that can measurably improve equity in real settings.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2022-08-09.
  • Applicants must submit their applications by 2024-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.
Apply for RFA DA 23 032

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Increasing Land, Capital, and Market Access Program

Previous opportunity: BLM IIJA Bureau of Land Management (AK) Wildlife Resource Management

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 23 032

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 23 032) also looked into and applied for these:

Funding Opportunity
NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) Apply for RFA DA 23 013

Funding Number: RFA DA 23 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) Apply for RFA DA 23 028

Funding Number: RFA DA 23 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) Apply for RFA DA 23 026

Funding Number: RFA DA 23 026
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) Apply for RFA DA 23 029

Funding Number: RFA DA 23 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) Apply for RFA DA 23 023

Funding Number: RFA DA 23 023
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 025

Funding Number: RFA DA 23 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) Apply for RFA DA 23 024

Funding Number: RFA DA 23 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional) Apply for RFA DA 23 031

Funding Number: RFA DA 23 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Clinical Trial Not Allowed) Apply for RFA DA 23 050

Funding Number: RFA DA 23 050
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
HEAL Initiative: Development and validation of virtual assessments to study children and caregivers in their natural environment (R01- Basic Experimental Studies with Humans Required) Apply for RFA DA 23 055

Funding Number: RFA DA 23 055
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) Apply for RFA CA 22 054

Funding Number: RFA CA 22 054
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Apply for RFA CA 22 041

Funding Number: RFA CA 22 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) Apply for RFA DA 23 056

Funding Number: RFA DA 23 056
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 030

Funding Number: RFA CA 22 030
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required) Apply for RFA CA 22 029

Funding Number: RFA CA 22 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required) Apply for RFA CA 22 028

Funding Number: RFA CA 22 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) Apply for PAR 22 234

Funding Number: PAR 22 234
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) Apply for PAR 22 200

Funding Number: PAR 22 200
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $3,000,000
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) Apply for RFA CA 22 050

Funding Number: RFA CA 22 050
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Apply for PAR 22 202

Funding Number: PAR 22 202
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $5,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 23 032", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: